Global Leukapheresis Market, By Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers) - Industry Trends and Forecast to 2030.
Leukapheresis Market Analysis and Size
The increasing incidence and prevalence of leukemia are among the important factors intensifying the growth and demand of the market. In addition, the high demand for leukopaks in clinical research, the growing number of blood donations, technological advancements, and the increasing demand and adoption of leukopaks in various applications such as R&D activities are also contributing to market growth over the forecast period of 2023 to 2030. Furthermore, the rising investments by major players for research activities, associated with increasing approvals for the process of isolating White Blood Corpuscles (WBC) for R&D activities, are also lifting the market growth The emerging economies and rising investments from pharma-biotech companies, academic institutes, and leading players are further expected to accelerate the market expansion offering significant growth opportunities for the market.
However, the high cost of therapeutic leukapheresis and leukopaks and the lack of skilled professionals and low adoption of therapeutic leukapheresis will curb the growth of the leukapheresis market, whereas the high cost of cellular immunotherapies and blood transfusion safety in developing countries have the potential to challenge market growth.
Data Bridge Market Research analyzes that the global leukapheresis market, which was USD 33,949.12 million in 2023, would rocket up to USD 60,785.85 million by 2030, and is expected to undergo a CAGR of 8.16% during the forecast period. "Multivitamin" dominates the product type segment of the market due to increasing awareness about leukapheresis.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Leukapheresis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Asahi Kasei Medical Co. Ltd (Japan), Haemonetics Corporation (U.S.), TERUMO BCT INC. (U.S.), STEMCELL Technologies Inc. (Canada), Fresenius SE & Co. KGaA (Germany), HemaCare (U.S.), B. Braun Melsungen AG (Germany), Caltag Medsystems Limited (U.K.), AllCells (U.S.), StemExpress (U.S.), Precision for Medicine, Inc. (U.S.), Lonza (Switzerland), BioIVT (U.S.), Lmb Technologie GmbH (Germany), Grifols, S.A (Spain), and Kaneka Pharma Europe NV (U.S.) among others
|
|
Market Opportunities
|
|
Market Definition
Leukapheresis is a medical procedure that involves the separation and collection of white blood cells (leukocytes) from a patient's blood. It is typically performed using specialized apheresis devices that employ centrifugation or filtration techniques to isolate and remove the white blood cells.
Leukapheresis is primarily used in the field of hematology and oncology for various purposes, including the collection of leukocytes for research purposes, the production of cellular therapeutics, and the treatment of certain blood disorders and cancers. The collected leukocytes can be further processed, manipulated, or infused back into the patient as part of therapeutic procedures.
Global Leukapheresis Market Dynamics
Drivers
- Increasing Prevalence of Blood Cancer
The rising incidence of blood cancers such as leukemia and lymphoma is one of the primary drivers of the leukapheresis market. Leukapheresis is commonly used for the collection of leukocytes from patients with blood cancer for various therapeutic purposes.
- Growing Demand for Stem Cell Transplantation
Leukapheresis plays a crucial role in stem cell transplantation procedures. As the demand for stem cell-based therapies continues to increase for the treatment of various diseases, including blood disorders, leukapheresis is experiencing significant growth.
- Supportive Reimbursement Policies
Favorable reimbursement policies by government and private insurance companies for leukapheresis procedures have encouraged their adoption. Reimbursement coverage for leukapheresis in the treatment of blood disorders and stem cell transplantation has positively influenced market growth.
Opportunity
- Advancements in Therapeutic Apheresis Techniques
Technological advancements in leukapheresis procedures have improved the efficiency, safety, and ease of the process. These advancements, such as the development of automated systems and improved separation techniques, have fueled the growth of the global leukapheresis market.
Restraint/Challenge
- Ethical and Regulatory Considerations
The collection and use of human cells, including leukocytes, raise ethical and regulatory considerations. Obtaining informed consent, ensuring patient privacy and data protection, and adhering to ethical guidelines can add complexities and may require stringent compliance, which may impact the market growth.
The global leukapheresis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on this market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.
Recent Development
- In June 2023, Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced a new partnership with Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organizations
Global Leukapheresis Market Scope
The global leukapheresis market is segmented into three notable segments based on type, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Type
- Leukapheresis Devices
- Apheresis Devices
- Leukapheresis Columns
- Cell Separators
- Leukoreduction Filters
- Leukapheresis Disposables
Application
- Research Applications
- Therapeutic Applications
End User
- Blood Component Providers and Blood Centres
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Transfusion Centres
Global Leukapheresis Market Regional Analysis/Insights
The global leukapheresis market is analyzed and market size insights and trends are provided by country, type, application, and end user as referenced above.
The countries covered in this market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
North America is expected to dominate the global leukapheresis market due to the increasing prevalence of influenza in that region.
Asia-Pacific is expected to be the fastest-growing region due to the rising awareness about influenza.
The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global leukapheresis market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2015-2020.
Competitive Landscape and Global Leukapheresis Market Share Analysis
The global leukapheresis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global leukapheresis market are:
- Asahi Kasei Medical Co. Ltd (Japan)
- Haemonetics Corporation (U.S.)
- TERUMO BCT INC. (U.S.)
- STEMCELL Technologies Inc. (Canada)
- Fresenius SE & Co. KGaA (Germany)
- HemaCare (U.S.)
- B. Braun Melsungen AG (Germany)
- Caltag Medsystems Limited (U.K.)
- AllCells (U.S.)
- StemExpress (U.S.)
- Precision for Medicine, Inc. (U.S.)
- Lonza (Switzerland)
- BioIVT (U.S.)
- Lmb Technologie GmbH (Germany)
- Grifols, S.A (Spain)
- Kaneka Pharma Europe NV (U.S.)
SKU-